A stable Re complex containing an imidazopyridine ligand with a high affinity for TSPO has been synthesized as a model for new 99mTc or 188/186Re-based radiopharmaceuticals to be used in SPECT diagnosis or in therapy, respectively. The new complex fac- [ReBr(CO)3(TZ6)], structurally characterized, showed high affinity (nanomolar concentration) for the target protein
Radionuclide therapy rapresent one of the most effective approach for the treatment of cancer. The b...
A novel procedure for the high-yield preparation of Re-188 radiopharmaceuticals containing a termina...
In 2021, it is projected that 1 in 2 men and 1 in 3 women will receive a new cancer diagnosis, resul...
A new tridentate 2-phenyl-imidazopyridin-dipropylacetamide ligand (CB239-H) with high (nanomolar) a...
The 18-kDa translocator protein (TSPO) levels are associated with brain, breast, and prostate cancer...
The 18-kDa translocator protein (TSPO) levels are associated with brain, breast, and prostate cancer...
The 18-kDa translocator protein (TSPO) levels are associated with brain, breast, and prostate cancer...
The 18-kDa translocator protein (TSPO) levels are associated with brain, breast, and prostate cancer...
We report on an efficient procedure for the preparation of [Re-188(N)(PNP)]-based complexes (where P...
We report on an efficient procedure for the preparation of [Re-188(N)(PNP)]-based complexes (where P...
Aim. Radionuclide therapy still remains one of the potentially most effective approaches for the tre...
The labeling of tumor targeting biomolecules with the ?-emitting nuclide Tc-99m and the ?-emitting n...
Accumulation of radiopharmaceuticals in the liver is frequently observed and represents in general a...
Abstract from public.pdf file.Dissertation supervisors: Drs. Silvia Jurisson and Heather Hennkens.In...
Radionuclide therapy rapresent one of the most effective approach for the treatment of cancer. The b...
Radionuclide therapy rapresent one of the most effective approach for the treatment of cancer. The b...
A novel procedure for the high-yield preparation of Re-188 radiopharmaceuticals containing a termina...
In 2021, it is projected that 1 in 2 men and 1 in 3 women will receive a new cancer diagnosis, resul...
A new tridentate 2-phenyl-imidazopyridin-dipropylacetamide ligand (CB239-H) with high (nanomolar) a...
The 18-kDa translocator protein (TSPO) levels are associated with brain, breast, and prostate cancer...
The 18-kDa translocator protein (TSPO) levels are associated with brain, breast, and prostate cancer...
The 18-kDa translocator protein (TSPO) levels are associated with brain, breast, and prostate cancer...
The 18-kDa translocator protein (TSPO) levels are associated with brain, breast, and prostate cancer...
We report on an efficient procedure for the preparation of [Re-188(N)(PNP)]-based complexes (where P...
We report on an efficient procedure for the preparation of [Re-188(N)(PNP)]-based complexes (where P...
Aim. Radionuclide therapy still remains one of the potentially most effective approaches for the tre...
The labeling of tumor targeting biomolecules with the ?-emitting nuclide Tc-99m and the ?-emitting n...
Accumulation of radiopharmaceuticals in the liver is frequently observed and represents in general a...
Abstract from public.pdf file.Dissertation supervisors: Drs. Silvia Jurisson and Heather Hennkens.In...
Radionuclide therapy rapresent one of the most effective approach for the treatment of cancer. The b...
Radionuclide therapy rapresent one of the most effective approach for the treatment of cancer. The b...
A novel procedure for the high-yield preparation of Re-188 radiopharmaceuticals containing a termina...
In 2021, it is projected that 1 in 2 men and 1 in 3 women will receive a new cancer diagnosis, resul...